ArticleCancers2021

The Soluble Urokinase-Type Plasminogen Activator Receptor as a Biomarker for Survival and Early Treatment Effect in Metastatic Colorectal Cancer.

Kristian Blomberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.